Aneesh Phadnis &Amp; Samie Modak

Stories by Aneesh Phadnis &Amp; Samie Modak

Made a killing in stocks? Algos could be behind it

Made a killing in stocks? Algos could be behind it

Rediff.com   6 Dec 2017

A little over 80 per cent of the orders placed on domestic stock markets are generated by algorithms. Samie Modak reports on the whats and whys of algos.

India's household wealth touches $5 trillion; M-cap rises 30%

India's household wealth touches $5 trillion; M-cap rises 30%

Rediff.com   15 Nov 2017

India's wealth grew by $451 billion, the eighth largest wealth gain globally.

After 15 years, Ranjit Shahani steps down as Novartis' India chief

After 15 years, Ranjit Shahani steps down as Novartis' India chief

Rediff.com   14 Nov 2017

The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in Hyderabad

Aadhaar-demat account linking: FPIs grappling with Sebi diktat

Aadhaar-demat account linking: FPIs grappling with Sebi diktat

Rediff.com   31 Oct 2017

Sebi directs freezing of all demat accounts not linked to Aadhaar by December 31

Why fund managers are not happy with Sebi

Why fund managers are not happy with Sebi

Rediff.com   29 Oct 2017

The stock market regulator's definition of large, mid, and small-cap companies has irked mutual fund managers, reports Samie Modak.

Pharma sector in alarm over govt's cure

Pharma sector in alarm over govt's cure

Rediff.com   28 Oct 2017

The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.

'Earnings growth will need to pick up to attract foreign flows'

'Earnings growth will need to pick up to attract foreign flows'

Rediff.com   26 Oct 2017

Given the strong growth in Asia and easy monetary stance taken by central banks other than the US Federal Reserve (US Fed), overseas investors will soon start re-investing in risky assets, says Abhiram Eleswarapu, head of equity research, BNP Paribas Securities India.

Why your takeoff from Delhi this winter may not be smooth

Why your takeoff from Delhi this winter may not be smooth

Rediff.com   21 Oct 2017

Delhi airport, the country's busiest, runs out of slots due to runway capacity constraints.

Muhurat trading sees worst performance in 10 years

Muhurat trading sees worst performance in 10 years

Rediff.com   20 Oct 2017

Trading in Samvat 2074 on Thursday got off to a rocky start, with the benchmark indices ending more than half a percent lower and the gauge for banking stocks dropping 1.25%.

In Q2, foreign investors sold $3.2 bn of Indian stocks

In Q2, foreign investors sold $3.2 bn of Indian stocks

Rediff.com   10 Oct 2017

This flight of capital began in early August due to risk-aversion created first by rising geopolitical tensions due to North Korean aggression and second by the US Fed's decision to shrink its balance sheet

MFs inflows top Rs 20,000-cr for 2nd straight month

MFs inflows top Rs 20,000-cr for 2nd straight month

Rediff.com   7 Oct 2017

Total assets under management (AUM) for September stood at Rs 20.4 lakh crore compared with Rs 20.6 lakh crore at the end of August.

India Inc may get a new governance code soon

India Inc may get a new governance code soon

Rediff.com   6 Oct 2017

Batting for greater transparency, a Sebi panel said sound corporate governance helped companies generate "significantly greater returns".

What spooked the markets on Friday?

What spooked the markets on Friday?

Rediff.com   23 Sep 2017

Market players said the sell-off was triggered by pessimism that the government may not be able to balance growth with macro-stability.

Bengaluru, Delhi airports lead the world

Bengaluru, Delhi airports lead the world

Rediff.com   23 Sep 2017

Bengaluru and Delhi airports had the fastest growth in passenger traffic in 2016 among global peers.

Why India's pharma cos prefer Gujarat over tax havens

Why India's pharma cos prefer Gujarat over tax havens

Rediff.com   23 Sep 2017

Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees

'If trading had not resumed, the attackers would have won'

'If trading had not resumed, the attackers would have won'

Rediff.com   20 Sep 2017

'We saw people tripping over each other, running, screaming.' 'You could see people running with their daily briefcase despite suffering deep cuts and blood pouring from them.'

Why GSK is changing its strategy after 93 years

Why GSK is changing its strategy after 93 years

Rediff.com   4 Sep 2017

Increased price control over branded generic medicines has affected its profitability

Ganpati, Durga, Lakshmi to the rescue of India Inc!

Ganpati, Durga, Lakshmi to the rescue of India Inc!

Rediff.com   4 Sep 2017

Brands in India are finding newer, more innovative ways to engage with a wider audience during festivals. But they still have a long way to go before they match global campaigns.

Why IndiGo is betting on low fare for long-haul

Why IndiGo is betting on low fare for long-haul

Rediff.com   11 Aug 2017

"The return fare on economy class to most European capitals from Mumbai are close to 50,000 plus. If an LCC can offer direct connectivity for a basic fare of 25,000 with additional top ups for meals, baggage and blankets, which further takes the fare to, say, 35,000, it is still a value deal."

Promoter stake in listed firms at 16-year low

Promoter stake in listed firms at 16-year low

Rediff.com   8 Aug 2017

For the first time since 2001, promoter stake in BSE 500 decisively below 50%